<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">34862271</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>28</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>03</Month>
        <Day>28</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">2575-1077</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>5</Volume>
            <Issue>3</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Mar</Month>
            </PubDate>
          </JournalIssue>
          <Title>Life science alliance</Title>
          <ISOAbbreviation>Life Sci Alliance</ISOAbbreviation>
        </Journal>
        <ArticleTitle>β-arrestin1 promotes tauopathy by transducing GPCR signaling, disrupting microtubules and autophagy.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e202101183</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.26508/lsa.202101183</ELocationID>
        <Abstract>
          <AbstractText>G protein-coupled receptors (GPCRs) have been shown to play integral roles in Alzheimer's disease pathogenesis. However, it is unclear how diverse GPCRs similarly affect Aβ and tau pathogenesis. GPCRs share a common mechanism of action via the β-arrestin scaffolding signaling complexes, which not only serve to desensitize GPCRs by internalization, but also mediate multiple downstream signaling events. As signaling via the GPCRs, β2-adrenergic receptor (β2AR), and metabotropic glutamate receptor 2 (mGluR2) promotes hyperphosphorylation of tau, we hypothesized that β-arrestin1 represents a point of convergence for such pathogenic activities. Here, we report that β-arrestins are not only essential for β2AR and mGluR2-mediated increase in pathogenic tau but also show that β-arrestin1 levels are increased in brains of Frontotemporal lobar degeneration (FTLD-tau) patients. Increased β-arrestin1 in turn drives the accumulation of pathogenic tau, whereas reduced <i>ARRB1</i> alleviates tauopathy and rescues impaired synaptic plasticity and cognitive impairments in PS19 mice. Biochemical and cellular studies show that β-arrestin1 drives tauopathy by destabilizing microtubules and impeding p62/SQSTM1 autophagy flux by interfering with p62 body formation, which promotes pathogenic tau accumulation.</AbstractText>
          <CopyrightInformation>© 2021 Woo et al.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Woo</LastName>
            <ForeName>Jung-Aa</ForeName>
            <Initials>JA</Initials>
            <Identifier Source="ORCID">0000-0002-9194-1361</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, USA jaw330@case.edu.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yan</LastName>
            <ForeName>Yan</ForeName>
            <Initials>Y</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Medicine, University of South Florida, College of Medicine, Tampa, FL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kee</LastName>
            <ForeName>Teresa R</ForeName>
            <Initials>TR</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Medicine, University of South Florida, College of Medicine, Tampa, FL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cazzaro</LastName>
            <ForeName>Sara</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Medicine, University of South Florida, College of Medicine, Tampa, FL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McGill Percy</LastName>
            <ForeName>Kyle C</ForeName>
            <Initials>KC</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wang</LastName>
            <ForeName>Xinming</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liu</LastName>
            <ForeName>Tian</ForeName>
            <Initials>T</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Liggett</LastName>
            <ForeName>Stephen B</ForeName>
            <Initials>SB</Initials>
            <Identifier Source="ORCID">0000-0002-0128-3669</Identifier>
            <AffiliationInfo>
              <Affiliation>Department of Molecular Pharmacology and Physiology, University of South Florida, College of Medicine, Tampa, FL, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kang</LastName>
            <ForeName>David E</ForeName>
            <Initials>DE</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathology, Case Western Reserve University, School of Medicine, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Louis Stokes Cleveland VA Medical Center, Cleveland, OH, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>I01 BX004680</GrantID>
            <Acronym>BX</Acronym>
            <Agency>BLRD VA</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>P50 AG025688</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>RF1 AG053060</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AG059721</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R01 AG067741</GrantID>
            <Acronym>AG</Acronym>
            <Agency>NIA NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
          <PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>03</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Life Sci Alliance</MedlineTA>
        <NlmUniqueID>101728869</NlmUniqueID>
        <ISSNLinking>2575-1077</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D043562">Receptors, G-Protein-Coupled</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D000071559">beta-Arrestin 1</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004198" MajorTopicYN="N">Disease Susceptibility</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015870" MajorTopicYN="N">Gene Expression</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D008870" MajorTopicYN="N">Microtubules</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D021381" MajorTopicYN="N">Protein Transport</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D043562" MajorTopicYN="N">Receptors, G-Protein-Coupled</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="Y">Signal Transduction</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D024801" MajorTopicYN="N">Tauopathies</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000071559" MajorTopicYN="N">beta-Arrestin 1</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2021</Year>
          <Month>8</Month>
          <Day>4</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>18</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2021</Year>
          <Month>11</Month>
          <Day>19</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>4</Day>
          <Hour>5</Hour>
          <Minute>37</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2021</Year>
          <Month>12</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">34862271</ArticleId>
        <ArticleId IdType="pmc">PMC8675912</ArticleId>
        <ArticleId IdType="doi">10.26508/lsa.202101183</ArticleId>
        <ArticleId IdType="pii">5/3/e202101183</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>AbdAlla S, Lother H, el Missiry A, Langer A, Sergeev P, el Faramawy Y, Quitterer U (2009. a) Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. J Biol Chem
284: 6554–6565. 10.1074/jbc.M807746200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M807746200</ArticleId>
            <ArticleId IdType="pubmed">19074441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>AbdAlla S, Lother H, el Missiry A, Sergeev P, Langer A, el Faramawy Y, Quitterer U (2009. b) Dominant negative AT2 receptor oligomers induce G-protein arrest and symptoms of neurodegeneration. J Biol Chem
284: 6566–6574. 10.1074/jbc.M808277200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M808277200</ArticleId>
            <ArticleId IdType="pubmed">19074439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alley GM, Bailey JA, Chen D, Ray B, Puli LK, Tanila H, Banerjee PK, Lahiri DK (2010) Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice. J Neurosci Res
88: 143–154. 10.1002/jnr.22172</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jnr.22172</ArticleId>
            <ArticleId IdType="pmc">PMC2783840</ArticleId>
            <ArticleId IdType="pubmed">19642202</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K (1997) Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: Sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A
94: 298–303. 10.1073/pnas.94.1.298</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.94.1.298</ArticleId>
            <ArticleId IdType="pmc">PMC19321</ArticleId>
            <ArticleId IdType="pubmed">8990203</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aplin A, Jasionowski T, Tuttle DL, Lenk SE, Dunn
WA, Jr (1992) Cytoskeletal elements are required for the formation and maturation of autophagic vacuoles. J Cell Physiol
152: 458–466. 10.1002/jcp.1041520304</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcp.1041520304</ArticleId>
            <ArticleId IdType="pubmed">1506410</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Attramadal H, Arriza JL, Aoki C, Dawson TM, Codina J, Kwatra MM, Snyder SH, Caron MG, Lefkowitz RJ (1992) Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family. J Biol Chem
267: 17882–17890. 10.1016/s0021-9258(19)37125-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0021-9258(19)37125-x</ArticleId>
            <ArticleId IdType="pubmed">1517224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Babu JR, Lamar Seibenhener M, Peng J, Strom AL, Kemppainen R, Cox N, Zhu H, Wooten MC, Diaz-Meco MT, Moscat J, et al.  (2008) Genetic inactivation of p62 leads to accumulation of hyperphosphorylated tau and neurodegeneration. J Neurochem
106: 107–120. 10.1111/j.1471-4159.2008.05340.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1471-4159.2008.05340.x</ArticleId>
            <ArticleId IdType="pubmed">18346206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bakshi P, Margenthaler E, Laporte V, Crawford F, Mullan M (2008) Novel role of CXCR2 in regulation of gamma-secretase activity. ACS Chem Biol
3: 777–789. 10.1021/cb800167a</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/cb800167a</ArticleId>
            <ArticleId IdType="pubmed">19067586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci
8: 663–672. 10.1038/nrn2194</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn2194</ArticleId>
            <ArticleId IdType="pubmed">17684513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Biernat J, Mandelkow EM (1999) The development of cell processes induced by tau protein requires phosphorylation of serine 262 and 356 in the repeat domain and is inhibited by phosphorylation in the proline-rich domains. Mol Biol Cell
10: 727–740. 10.1091/mbc.10.3.727</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1091/mbc.10.3.727</ArticleId>
            <ArticleId IdType="pmc">PMC25198</ArticleId>
            <ArticleId IdType="pubmed">10069814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boecker CA, Holzbaur EL (2019) Vesicular degradation pathways in neurons: At the crossroads of autophagy and endo-lysosomal degradation. Curr Opin Neurobiol
57: 94–101. 10.1016/j.conb.2019.01.005</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.conb.2019.01.005</ArticleId>
            <ArticleId IdType="pmc">PMC6629518</ArticleId>
            <ArticleId IdType="pubmed">30784982</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Bohn LM, Lefkowitz RJ, Gainetdinov RR, Peppel K, Caron MG, Lin FT (1999) Enhanced morphine analgesia in mice lacking beta-arrestin 2. Science
286: 2495–2498. 10.1126/science.286.5449.2495</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.286.5449.2495</ArticleId>
            <ArticleId IdType="pubmed">10617462</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Boularan C, Scott MG, Bourougaa K, Bellal M, Esteve E, Thuret A, Benmerah A, Tramier M, Coppey-Moisan M, Labbé-Jullié C, et al.  (2007) beta-arrestin 2 oligomerization controls the Mdm2-dependent inhibition of p53. Proc Natl Acad Sci U S A
104: 18061–18066. 10.1073/pnas.0705550104</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0705550104</ArticleId>
            <ArticleId IdType="pmc">PMC2084296</ArticleId>
            <ArticleId IdType="pubmed">17984062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Breitman M, Kook S, Gimenez LE, Lizama BN, Palazzo MC, Gurevich EV, Gurevich VV (2012) Silent scaffolds: Inhibition OF c-Jun N-terminal kinase 3 activity in cell by dominant-negative arrestin-3 mutant. J Biol Chem
287: 19653–19664. 10.1074/jbc.M112.358192</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M112.358192</ArticleId>
            <ArticleId IdType="pmc">PMC3366000</ArticleId>
            <ArticleId IdType="pubmed">22523077</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chalermpalanupap T, Schroeder J, Rorabaugh J, Liles LC, Lah J, Levey A, Weinshenker D (2018) Locus coeruleus ablation exacerbates cognitive deficits, neuropathology, and lethality in P301S tau transgenic mice. J Neurosci
38: 74–92. 10.1523/JNEUROSCI.1483-17.2017</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.1483-17.2017</ArticleId>
            <ArticleId IdType="pmc">PMC5761438</ArticleId>
            <ArticleId IdType="pubmed">29133432</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cha-Molstad H, Yu JE, Feng Z, Lee SH, Kim JG, Yang P, Han B, Sung KW, Yoo YD, Hwang J, et al.  (2017) p62/SQSTM1/Sequestosome-1 is an N-recognin of the N-end rule pathway which modulates autophagosome biogenesis. Nat Commun
8: 102. 10.1038/s41467-017-00085-7</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41467-017-00085-7</ArticleId>
            <ArticleId IdType="pmc">PMC5524641</ArticleId>
            <ArticleId IdType="pubmed">28740232</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng XT, Zhou B, Lin MY, Cai Q, Sheng ZH (2015) Axonal autophagosomes use the ride-on service for retrograde transport toward the soma. Autophagy
11: 1434–1436. 10.1080/15548627.2015.1062203</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15548627.2015.1062203</ArticleId>
            <ArticleId IdType="pmc">PMC4590659</ArticleId>
            <ArticleId IdType="pubmed">26102591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ciuffa R, Lamark T, Tarafder AK, Guesdon A, Rybina S, Hagen WJ, Johansen T, Sachse C (2015) The selective autophagy receptor p62 forms a flexible filamentous helical scaffold. Cell Rep
11: 748–758. 10.1016/j.celrep.2015.03.062</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2015.03.062</ArticleId>
            <ArticleId IdType="pubmed">25921531</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cleveland DW, Hwo SY, Kirschner MW (1977) Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J Mol Biol
116: 207–225. 10.1016/0022-2836(77)90213-3</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0022-2836(77)90213-3</ArticleId>
            <ArticleId IdType="pubmed">599557</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Conner DA, Mathier MA, Mortensen RM, Christe M, Vatner SF, Seidman CE, Seidman JG (1997) beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ Res
81: 1021–1026. 10.1161/01.res.81.6.1021</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/01.res.81.6.1021</ArticleId>
            <ArticleId IdType="pubmed">9400383</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dinculescu A, McDowell JH, Amici SA, Dugger DR, Richards N, Hargrave PA, Smith WC (2002) Insertional mutagenesis and immunochemical analysis of visual arrestin interaction with rhodopsin. J Biol Chem
277: 11703–11708. 10.1074/jbc.M111833200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111833200</ArticleId>
            <ArticleId IdType="pubmed">11809770</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dobarro M, Gerenu G, Ramírez MJ (2013) Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer’s transgenic mice. Int J Neuropsychopharmacol
16: 2245–2257. 10.1017/S1461145713000631</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/S1461145713000631</ArticleId>
            <ArticleId IdType="pubmed">23768694</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Farfel-Becker T, Roney JC, Cheng XT, Li S, Cuddy SR, Sheng ZH (2019) Neuronal soma-derived degradative lysosomes are continuously delivered to distal axons to maintain local degradation capacity. Cell Rep
28: 51–64.e4. 10.1016/j.celrep.2019.06.013</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.celrep.2019.06.013</ArticleId>
            <ArticleId IdType="pmc">PMC6696943</ArticleId>
            <ArticleId IdType="pubmed">31269450</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Fass E, Shvets E, Degani I, Hirschberg K, Elazar Z (2006) Microtubules support production of starvation-induced autophagosomes but not their targeting and fusion with lysosomes. J Biol Chem
281: 36303–36316. 10.1074/jbc.M607031200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M607031200</ArticleId>
            <ArticleId IdType="pubmed">16963441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goedert M, Wischik CM, Crowther RA, Walker JE, Klug A (1988) Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: Identification as the microtubule-associated protein tau. Proc Natl Acad Sci U S A
85: 4051–4055. 10.1073/pnas.85.11.4051</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.85.11.4051</ArticleId>
            <ArticleId IdType="pmc">PMC280359</ArticleId>
            <ArticleId IdType="pubmed">3131773</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Goodman
OB, Jr, Krupnick JG, Santini F, Gurevich VV, Penn RB, Gagnon AW, Keen JH, Benovic JL (1996) Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature
383: 447–450. 10.1038/383447a0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/383447a0</ArticleId>
            <ArticleId IdType="pubmed">8837779</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gurevich VV, Benovic JL (1993) Visual arrestin interaction with rhodopsin. Sequential multisite binding ensures strict selectivity toward light-activated phosphorylated rhodopsin. J Biol Chem
268: 11628–11638. 10.1016/s0021-9258(19)50248-4</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0021-9258(19)50248-4</ArticleId>
            <ArticleId IdType="pubmed">8505295</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gurevich VV, Dion SB, Onorato JJ, Ptasienski J, Kim CM, Sterne-Marr R, Hosey MM, Benovic JL (1995) Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, beta 2-adrenergic, and m2 muscarinic cholinergic receptors. J Biol Chem
270: 720–731. 10.1074/jbc.270.2.720</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.270.2.720</ArticleId>
            <ArticleId IdType="pubmed">7822302</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gurevich VV, Gurevich EV (2014) Overview of different mechanisms of arrestin-mediated signaling. Curr Protoc Pharmacol
67: 2.10.1–2.10.9. 10.1002/0471141755.ph0210s67</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/0471141755.ph0210s67</ArticleId>
            <ArticleId IdType="pmc">PMC4260930</ArticleId>
            <ArticleId IdType="pubmed">25446289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gurevich VV, Gurevich EV (2006) The structural basis of arrestin-mediated regulation of G-protein-coupled receptors. Pharmacol Ther
110: 465–502. 10.1016/j.pharmthera.2005.09.008</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.pharmthera.2005.09.008</ArticleId>
            <ArticleId IdType="pmc">PMC2562282</ArticleId>
            <ArticleId IdType="pubmed">16460808</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanson SM, Cleghorn WM, Francis DJ, Vishnivetskiy SA, Raman D, Song X, Nair KS, Slepak VZ, Klug CS, Gurevich VV (2007. a) Arrestin mobilizes signaling proteins to the cytoskeleton and redirects their activity. J Mol Biol
368: 375–387. 10.1016/j.jmb.2007.02.053</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jmb.2007.02.053</ArticleId>
            <ArticleId IdType="pmc">PMC1904837</ArticleId>
            <ArticleId IdType="pubmed">17359998</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hanson SM, Gurevich EV, Vishnivetskiy SA, Ahmed MR, Song X, Gurevich VV (2007. b) Each rhodopsin molecule binds its own arrestin. Proc Natl Acad Sci U S A
104: 3125–3128. 10.1073/pnas.0610886104</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0610886104</ArticleId>
            <ArticleId IdType="pmc">PMC1805568</ArticleId>
            <ArticleId IdType="pubmed">17360618</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoover BR, Reed MN, Su J, Penrod RD, Kotilinek LA, Grant MK, Pitstick R, Carlson GA, Lanier LM, Yuan LL, et al.  (2010) Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration. Neuron
68: 1067–1081. 10.1016/j.neuron.2010.11.030</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2010.11.030</ArticleId>
            <ArticleId IdType="pmc">PMC3026458</ArticleId>
            <ArticleId IdType="pubmed">21172610</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Irwin DJ, Cairns NJ, Grossman M, McMillan CT, Lee EB, Van Deerlin VM, Lee VM, Trojanowski JQ (2015) Frontotemporal lobar degeneration: Defining phenotypic diversity through personalized medicine. Acta Neuropathol
129: 469–491. 10.1007/s00401-014-1380-1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-014-1380-1</ArticleId>
            <ArticleId IdType="pmc">PMC4369168</ArticleId>
            <ArticleId IdType="pubmed">25549971</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Itakura E, Mizushima N (2011) p62 Targeting to the autophagosome formation site requires self-oligomerization but not LC3 binding. J Cell Biol
192: 17–27. 10.1083/jcb.201009067</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201009067</ArticleId>
            <ArticleId IdType="pmc">PMC3019556</ArticleId>
            <ArticleId IdType="pubmed">21220506</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, Unnerstall JR (1989) Adrenergic receptors in aging and Alzheimer's disease: Increased beta 2-receptors in prefrontal cortex and hippocampus. J Neurochem
53: 1772–1781. 10.1111/j.1471-4159.1989.tb09242.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1471-4159.1989.tb09242.x</ArticleId>
            <ArticleId IdType="pubmed">2553864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Katsuragi Y, Ichimura Y, Komatsu M (2015) p62/SQSTM1 functions as a signaling hub and an autophagy adaptor. FEBS J
282: 4672–4678. 10.1111/febs.13540</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/febs.13540</ArticleId>
            <ArticleId IdType="pubmed">26432171</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim M, Vishnivetskiy SA, Van Eps N, Alexander NS, Cleghorn WM, Zhan X, Hanson SM, Morizumi T, Ernst OP, Meiler J, et al.  (2012) Conformation of receptor-bound visual arrestin. Proc Natl Acad Sci U S A
109: 18407–18412. 10.1073/pnas.1216304109</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1216304109</ArticleId>
            <ArticleId IdType="pmc">PMC3494953</ArticleId>
            <ArticleId IdType="pubmed">23091036</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>King A, Al-Sarraj S, Troakes C, Smith BN, Maekawa S, Iovino M, Spillantini MG, Shaw CE (2013) Mixed tau, TDP-43 and p62 pathology in FTLD associated with a C9ORF72 repeat expansion and p.Ala239Thr MAPT (tau) variant. Acta Neuropathol
125: 303–310. 10.1007/s00401-012-1050-0</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-012-1050-0</ArticleId>
            <ArticleId IdType="pubmed">23053136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kohout TA, Lin FS, Perry SJ, Conner DA, Lefkowitz RJ (2001) beta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and trafficking. Proc Natl Acad Sci U S A
98: 1601–1606. 10.1073/pnas.041608198</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.041608198</ArticleId>
            <ArticleId IdType="pmc">PMC29303</ArticleId>
            <ArticleId IdType="pubmed">11171997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuusisto E, Salminen A, Alafuzoff I (2002) Early accumulation of p62 in neurofibrillary tangles in Alzheimer's disease: Possible role in tangle formation. Neuropathol Appl Neurobiol
28: 228–237. 10.1046/j.1365-2990.2002.00394.x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2990.2002.00394.x</ArticleId>
            <ArticleId IdType="pubmed">12060347</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Larsen KB, Lamark T, Øvervatn A, Harneshaug I, Johansen T, Bjørkøy G (2010) A reporter cell system to monitor autophagy based on p62/SQSTM1. Autophagy
6: 784–793. 10.4161/auto.6.6.12510</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4161/auto.6.6.12510</ArticleId>
            <ArticleId IdType="pubmed">20574168</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lashley T, Rohrer JD, Mead S, Revesz T (2015) Review: An update on clinical, genetic and pathological aspects of frontotemporal lobar degenerations. Neuropathol Appl Neurobiol
41: 858–881. 10.1111/nan.12250</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/nan.12250</ArticleId>
            <ArticleId IdType="pubmed">26041104</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee HG, Ogawa O, Zhu X, O’Neill MJ, Petersen RB, Castellani RJ, Ghanbari H, Perry G, Smith MA (2004) Aberrant expression of metabotropic glutamate receptor 2 in the vulnerable neurons of Alzheimer's disease. Acta Neuropathol
107: 365–371. 10.1007/s00401-004-0820-8</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-004-0820-8</ArticleId>
            <ArticleId IdType="pubmed">14872255</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee HG, Zhu X, Casadesus G, Pallàs M, Camins A, O’Neill MJ, Nakanishi S, Perry G, Smith MA (2009) The effect of mGluR2 activation on signal transduction pathways and neuronal cell survival. Brain Res
1249: 244–250. 10.1016/j.brainres.2008.10.055</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2008.10.055</ArticleId>
            <ArticleId IdType="pmc">PMC2698437</ArticleId>
            <ArticleId IdType="pubmed">19026996</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee S, Sato Y, Nixon RA (2011) Lysosomal proteolysis inhibition selectively disrupts axonal transport of degradative organelles and causes an Alzheimer’s-like axonal dystrophy. J Neurosci
31: 7817–7830. 10.1523/JNEUROSCI.6412-10.2011</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.6412-10.2011</ArticleId>
            <ArticleId IdType="pmc">PMC3351137</ArticleId>
            <ArticleId IdType="pubmed">21613495</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lefkowitz RJ, Rajagopal K, Whalen EJ (2006) New roles for beta-arrestins in cell signaling: Not just for seven-transmembrane receptors. Mol Cell
24: 643–652. 10.1016/j.molcel.2006.11.007</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.molcel.2006.11.007</ArticleId>
            <ArticleId IdType="pubmed">17157248</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu X, Zhao X, Zeng X, Bossers K, Swaab DF, Zhao J, Pei G (2013) β-Arrestin1 regulates γ-secretase complex assembly and modulates amyloid-β pathology. Cell Res
23: 351–365. 10.1038/cr.2012.167</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/cr.2012.167</ArticleId>
            <ArticleId IdType="pmc">PMC3587707</ArticleId>
            <ArticleId IdType="pubmed">23208420</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lohse MJ, Benovic JL, Codina J, Caron MG, Lefkowitz RJ (1990) beta-Arrestin: A protein that regulates beta-adrenergic receptor function. Science
248: 1547–1550. 10.1126/science.2163110</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.2163110</ArticleId>
            <ArticleId IdType="pubmed">2163110</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luong K, Nguyen LT (2013) The role of beta-adrenergic receptor blockers in Alzheimer's disease: Potential genetic and cellular signaling mechanisms. Am J Alzheimers Dis Other Demen
28: 427–439. 10.1177/1533317513488924</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/1533317513488924</ArticleId>
            <ArticleId IdType="pubmed">23689075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Luttrell LM, Ferguson SS, Daaka Y, Miller WE, Maudsley S, Della Rocca GJ, Lin F, Kawakatsu H, Owada K, Luttrell DK, et al.  (1999) Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science
283: 655–661. 10.1126/science.283.5402.655</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.283.5402.655</ArticleId>
            <ArticleId IdType="pubmed">9924018</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maday S, Wallace KE, Holzbaur EL (2012) Autophagosomes initiate distally and mature during transport toward the cell soma in primary neurons. J Cell Biol
196: 407–417. 10.1083/jcb.201106120</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1083/jcb.201106120</ArticleId>
            <ArticleId IdType="pmc">PMC3283992</ArticleId>
            <ArticleId IdType="pubmed">22331844</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mauvezin C, Neufeld TP (2015) Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A/SERCA-dependent autophagosome-lysosome fusion. Autophagy
11: 1437–1438. 10.1080/15548627.2015.1066957</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15548627.2015.1066957</ArticleId>
            <ArticleId IdType="pmc">PMC4590655</ArticleId>
            <ArticleId IdType="pubmed">26156798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Milano SK, Kim YM, Stefano FP, Benovic JL, Brenner C (2006) Nonvisual arrestin oligomerization and cellular localization are regulated by inositol hexakisphosphate binding. J Biol Chem
281: 9812–9823. 10.1074/jbc.M512703200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M512703200</ArticleId>
            <ArticleId IdType="pubmed">16439357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Minkeviciene R, Banerjee P, Tanila H (2004) Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther
311: 677–682. 10.1124/jpet.104.071027</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1124/jpet.104.071027</ArticleId>
            <ArticleId IdType="pubmed">15192085</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moore CA, Milano SK, Benovic JL (2007) Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol
69: 451–482. 10.1146/annurev.physiol.69.022405.154712</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.physiol.69.022405.154712</ArticleId>
            <ArticleId IdType="pubmed">17037978</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Morris R (1981) Spatial localisation does not depend on the presence of local cues. Learn Motiv
12: 239–260. </Citation>
        </Reference>
        <Reference>
          <Citation>Ni Y, Zhao X, Bao G, Zou L, Teng L, Wang Z, Song M, Xiong J, Bai Y, Pei G (2006) Activation of beta2-adrenergic receptor stimulates gamma-secretase activity and accelerates amyloid plaque formation. Nat Med
12: 1390–1396. 10.1038/nm1485</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm1485</ArticleId>
            <ArticleId IdType="pubmed">17115048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nixon RA, Wegiel J, Kumar A, Yu WH, Peterhoff C, Cataldo A, Cuervo AM (2005) Extensive involvement of autophagy in Alzheimer disease: An immuno-electron microscopy study. J Neuropathol Exp Neurol
64: 113–122. 10.1093/jnen/64.2.113</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jnen/64.2.113</ArticleId>
            <ArticleId IdType="pubmed">15751225</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palczewski K, Buczylko J, Ohguro H, Annan RS, Carr SA, Crabb JW, Kaplan MW, Johnson RS, Walsh KA (1994) Characterization of a truncated form of arrestin isolated from bovine rod outer segments. Protein Sci
3: 314–324. 10.1002/pro.5560030215</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/pro.5560030215</ArticleId>
            <ArticleId IdType="pmc">PMC2142797</ArticleId>
            <ArticleId IdType="pubmed">8003967</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pankiv S, Clausen TH, Lamark T, Brech A, Bruun JA, Outzen H, Øvervatn A, Bjørkøy G, Johansen T (2007) p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem
282: 24131–24145. 10.1074/jbc.M702824200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M702824200</ArticleId>
            <ArticleId IdType="pubmed">17580304</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patterson KR, Remmers C, Fu Y, Brooker S, Kanaan NM, Vana L, Ward S, Reyes JF, Philibert K, Glucksman MJ, et al.  (2011) Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease. J Biol Chem
286: 23063–23076. 10.1074/jbc.M111.237974</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M111.237974</ArticleId>
            <ArticleId IdType="pmc">PMC3123074</ArticleId>
            <ArticleId IdType="pubmed">21550980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pontrello CG, Sun MY, Lin A, Fiacco TA, DeFea KA, Ethell IM (2012) Cofilin under control of β-arrestin-2 in NMDA-dependent dendritic spine plasticity, long-term depression (LTD), and learning. Proc Natl Acad Sci U S A
109: E442–E451. 10.1073/pnas.1118803109</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1118803109</ArticleId>
            <ArticleId IdType="pmc">PMC3289389</ArticleId>
            <ArticleId IdType="pubmed">22308427</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pulvermüller A, Schroder K, Fischer T, Hofmann KP (2000) Interactions of metarhodopsin II. Arrestin peptides compete with arrestin and transducin. J Biol Chem
275: 37679–37685. 10.1074/jbc.M006776200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M006776200</ArticleId>
            <ArticleId IdType="pubmed">10969086</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rosenberg PB, Mielke MM, Tschanz J, Cook L, Corcoran C, Hayden KM, Norton M, Rabins PV, Green RC, Welsh-Bohmer KA, et al.  (2008) Effects of cardiovascular medications on rate of functional decline in Alzheimer disease. Am J Geriatr Psychiatry
16: 883–892. 10.1097/JGP.0b013e318181276a</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/JGP.0b013e318181276a</ArticleId>
            <ArticleId IdType="pmc">PMC2676234</ArticleId>
            <ArticleId IdType="pubmed">18978249</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sanchez-Varo R, Trujillo-Estrada L, Sanchez-Mejias E, Torres M, Baglietto-Vargas D, Moreno-Gonzalez I, De Castro V, Jimenez S, Ruano D, Vizuete M, et al.  (2012) Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer's mice hippocampus. Acta Neuropathol
123: 53–70. 10.1007/s00401-011-0896-x</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00401-011-0896-x</ArticleId>
            <ArticleId IdType="pmc">PMC3249205</ArticleId>
            <ArticleId IdType="pubmed">22020633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shinohara T, Dietzschold B, Craft CM, Wistow G, Early JJ, Donoso LA, Horwitz J, Tao R (1987) Primary and secondary structure of bovine retinal S antigen (48-kDa protein). Proc Natl Acad Sci U S A
84: 6975–6979. 10.1073/pnas.84.20.6975</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.84.20.6975</ArticleId>
            <ArticleId IdType="pmc">PMC299211</ArticleId>
            <ArticleId IdType="pubmed">3478675</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Smith JS, Rajagopal S (2016) The β-arrestins: Multifunctional regulators of G protein-coupled receptors. J Biol Chem
291: 8969–8977. 10.1074/jbc.R115.713313</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.R115.713313</ArticleId>
            <ArticleId IdType="pmc">PMC4861465</ArticleId>
            <ArticleId IdType="pubmed">26984408</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Storez H, Scott MG, Issafras H, Burtey A, Benmerah A, Muntaner O, Piolot T, Tramier M, Coppey-Moisan M, Bouvier M, et al.  (2005) Homo- and hetero-oligomerization of beta-arrestins in living cells. J Biol Chem
280: 40210–40215. 10.1074/jbc.M508001200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M508001200</ArticleId>
            <ArticleId IdType="pubmed">16199535</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun L, Wang X, Liu S, Wang Q, Wang J, Bennecib M, Gong CX, Sengupta A, Grundke-Iqbal I, Iqbal K (2005) Bilateral injection of isoproterenol into hippocampus induces Alzheimer-like hyperphosphorylation of tau and spatial memory deficit in rat. FEBS Lett
579: 251–258. 10.1016/j.febslet.2004.11.083</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.febslet.2004.11.083</ArticleId>
            <ArticleId IdType="pubmed">15620722</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thathiah A, Spittaels K, Hoffmann M, Staes M, Cohen A, Horré K, Vanbrabant M, Coun F, Baekelandt V, Delacourte A, et al.  (2009) The orphan G protein-coupled receptor 3 modulates amyloid-beta peptide generation in neurons. Science
323: 946–951. 10.1126/science.1160649</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.1160649</ArticleId>
            <ArticleId IdType="pubmed">19213921</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thathiah A, Horré K, Snellinx A, Vandewyer E, Huang Y, Ciesielska M, De Kloe G, Munck S, De Strooper B (2013) β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease. Nat Med
19: 43–49. 10.1038/nm.3023</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.3023</ArticleId>
            <ArticleId IdType="pubmed">23202293</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vishnivetskiy SA, Gimenez LE, Francis DJ, Hanson SM, Hubbell WL, Klug CS, Gurevich VV (2011) Few residues within an extensive binding interface drive receptor interaction and determine the specificity of arrestin proteins. J Biol Chem
286: 24288–24299. 10.1074/jbc.M110.213835</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M110.213835</ArticleId>
            <ArticleId IdType="pmc">PMC3129209</ArticleId>
            <ArticleId IdType="pubmed">21471193</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>von Bergen M, Barghorn S, Li L, Marx A, Biernat J, Mandelkow EM, Mandelkow E (2001) Mutations of tau protein in frontotemporal dementia promote aggregation of paired helical filaments by enhancing local beta-structure. J Biol Chem
276: 48165–48174. 10.1074/jbc.M105196200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M105196200</ArticleId>
            <ArticleId IdType="pubmed">11606569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang T, Martin S, Papadopulos A, Harper CB, Mavlyutov TA, Niranjan D, Glass NR, Cooper-White JJ, Sibarita JB, Choquet D, et al.  (2015) Control of autophagosome axonal retrograde flux by presynaptic activity unveiled using botulinum neurotoxin type a. J Neurosci
35: 6179–6194. 10.1523/JNEUROSCI.3757-14.2015</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1523/JNEUROSCI.3757-14.2015</ArticleId>
            <ArticleId IdType="pmc">PMC4787026</ArticleId>
            <ArticleId IdType="pubmed">25878289</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci
17: 5–21. 10.1038/nrn.2015.1</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrn.2015.1</ArticleId>
            <ArticleId IdType="pubmed">26631930</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ward SM, Himmelstein DS, Lancia JK, Binder LI (2012) Tau oligomers and tau toxicity in neurodegenerative disease. Biochem Soc Trans
40: 667–671. 10.1042/BST20120134</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/BST20120134</ArticleId>
            <ArticleId IdType="pmc">PMC3704193</ArticleId>
            <ArticleId IdType="pubmed">22817713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wilden U, Hall SW, Kühn H (1986) Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc Natl Acad Sci U S A
83: 1174–1178. 10.1073/pnas.83.5.1174</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.83.5.1174</ArticleId>
            <ArticleId IdType="pmc">PMC323037</ArticleId>
            <ArticleId IdType="pubmed">3006038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wisely EV, Xiang YK, Oddo S (2014) Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies. Hum Mol Genet
23: 4024–4034. 10.1093/hmg/ddu116</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddu116</ArticleId>
            <ArticleId IdType="pmc">PMC4082366</ArticleId>
            <ArticleId IdType="pubmed">24626633</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woo JA, Liu T, Fang CC, Castaño MA, Kee T, Yrigoin K, Yan Y, Cazzaro S, Matlack J, Wang X, et al.  (2020) β-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregates. Proc Natl Acad Sci U S A
117: 5006–5015. 10.1073/pnas.1917194117</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1917194117</ArticleId>
            <ArticleId IdType="pmc">PMC7060747</ArticleId>
            <ArticleId IdType="pubmed">32071246</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woo JA, Liu T, Fang CC, Cazzaro S, Kee T, LePochat P, Yrigoin K, Penn C, Zhao X, Wang X, et al.  (2019) Activated cofilin exacerbates tau pathology by impairing tau-mediated microtubule dynamics. Commun Biol
2: 112. 10.1038/s42003-019-0359-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s42003-019-0359-9</ArticleId>
            <ArticleId IdType="pmc">PMC6430779</ArticleId>
            <ArticleId IdType="pubmed">30911686</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woo JA, Liu T, Trotter C, Fang CC, De Narvaez E, LePochat P, Maslar D, Bukhari A, Zhao X, Deonarine A, et al.  (2017. a) Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity. Nat Commun
8: 15558. 10.1038/ncomms15558</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms15558</ArticleId>
            <ArticleId IdType="pmc">PMC5467170</ArticleId>
            <ArticleId IdType="pubmed">28585542</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Woo JA, Liu T, Zhao X, Trotter C, Yrigoin K, Cazzaro S, Narvaez E, Khan H, Witas R, Bukhari A, et al.  (2017. b) Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes. Hum Mol Genet
26: 3973–3988. 10.1093/hmg/ddx284</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/hmg/ddx284</ArticleId>
            <ArticleId IdType="pmc">PMC6075219</ArticleId>
            <ArticleId IdType="pubmed">29016855</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wurzer B, Zaffagnini G, Fracchiolla D, Turco E, Abert C, Romanov J, Martens S (2015) Oligomerization of p62 allows for selection of ubiquitinated cargo and isolation membrane during selective autophagy. Elife
4: e08941. 10.7554/eLife.08941</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.08941</ArticleId>
            <ArticleId IdType="pmc">PMC4684078</ArticleId>
            <ArticleId IdType="pubmed">26413874</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu H, Rösler T, Carlsson T, de Andrade A, Fiala O, Matthias H, Wolfgang O, Michel G, Aigner A, Höglinger G (2014) Tau silencing by siRNA in the P301S mouse model of tauopathy. Curr Gene Ther
14: 343–351. 10.2174/156652321405140926160602</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/156652321405140926160602</ArticleId>
            <ArticleId IdType="pubmed">25687501</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y, Zhang S, Zheng H (2019) The cargo receptor SQSTM1 ameliorates neurofibrillary tangle pathology and spreading through selective targeting of pathological MAPT (microtubule associated protein tau). Autophagy
15: 583–598. 10.1080/15548627.2018.1532258</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/15548627.2018.1532258</ArticleId>
            <ArticleId IdType="pmc">PMC6526869</ArticleId>
            <ArticleId IdType="pubmed">30290707</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamada K, Holth JK, Liao F, Stewart FR, Mahan TE, Jiang H, Cirrito JR, Patel TK, Hochgräfe K, Mandelkow EM, et al.  (2014) Neuronal activity regulates extracellular tau in vivo. J Exp Med
211: 387–393. 10.1084/jem.20131685</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1084/jem.20131685</ArticleId>
            <ArticleId IdType="pmc">PMC3949564</ArticleId>
            <ArticleId IdType="pubmed">24534188</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamaki K, Takahashi Y, Sakuragi S, Matsubara K (1987) Molecular cloning of the S-antigen cDNA from bovine retina. Biochem Biophys Res Commun
142: 904–910. 10.1016/0006-291x(87)91499-9</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0006-291x(87)91499-9</ArticleId>
            <ArticleId IdType="pubmed">2950857</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yamamoto A, Tagawa Y, Yoshimori T, Moriyama Y, Masaki R, Tashiro Y (1998) Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells. Cell Struct Funct
23: 33–42. 10.1247/csf.23.33</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1247/csf.23.33</ArticleId>
            <ArticleId IdType="pubmed">9639028</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang DS, Kumar A, Stavrides P, Peterson J, Peterhoff CM, Pawlik M, Levy E, Cataldo AM, Nixon RA (2008) Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease. Am J Pathol
173: 665–681. 10.2353/ajpath.2008.071176</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2353/ajpath.2008.071176</ArticleId>
            <ArticleId IdType="pmc">PMC2527090</ArticleId>
            <ArticleId IdType="pubmed">18688038</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshimori T, Yamamoto A, Moriyama Y, Futai M, Tashiro Y (1991) Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J Biol Chem
266: 17707–17712. 10.1016/s0021-9258(19)47429-2</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s0021-9258(19)47429-2</ArticleId>
            <ArticleId IdType="pubmed">1832676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yoshiyama Y, Higuchi M, Zhang B, Huang SM, Iwata N, Saido TC, Maeda J, Suhara T, Trojanowski JQ, Lee VM (2007) Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model. Neuron
53: 337–351. 10.1016/j.neuron.2007.01.010</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.neuron.2007.01.010</ArticleId>
            <ArticleId IdType="pubmed">17270732</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yu JT, Tan L, Ou JR, Zhu JX, Liu K, Song JH, Sun YP (2008) Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer’s disease susceptibility. Brain Res
1210: 216–222. 10.1016/j.brainres.2008.03.019</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.brainres.2008.03.019</ArticleId>
            <ArticleId IdType="pubmed">18423577</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang M, Liu X, Zhang Y, Zhao J (2010) Loss of betaarrestin1 and betaarrestin2 contributes to pulmonary hypoplasia and neonatal lethality in mice. Dev Biol
339: 407–417. 10.1016/j.ydbio.2009.12.042</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ydbio.2009.12.042</ArticleId>
            <ArticleId IdType="pubmed">20060823</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng X, Wang W, Liu R, Huang H, Zhang R, Sun L (2012) Effect of p62 on tau hyperphosphorylation in a rat model of Alzheimer's disease. Neural Regen Res
7: 1304–1311. 10.3969/j.issn.1673-5374.2012.17.004</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3969/j.issn.1673-5374.2012.17.004</ArticleId>
            <ArticleId IdType="pmc">PMC4308800</ArticleId>
            <ArticleId IdType="pubmed">25657660</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhuang T, Chen Q, Cho MK, Vishnivetskiy SA, Iverson TM, Gurevich VV, Sanders CR (2013) Involvement of distinct arrestin-1 elements in binding to different functional forms of rhodopsin. Proc Natl Acad Sci U S A
110: 942–947. 10.1073/pnas.1215176110</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1215176110</ArticleId>
            <ArticleId IdType="pmc">PMC3549108</ArticleId>
            <ArticleId IdType="pubmed">23277586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zoudilova M, Kumar P, Ge L, Wang P, Bokoch GM, DeFea KA (2007) Beta-arrestin-dependent regulation of the cofilin pathway downstream of protease-activated receptor-2. J Biol Chem
282: 20634–20646. 10.1074/jbc.M701391200</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M701391200</ArticleId>
            <ArticleId IdType="pubmed">17500066</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zoudilova M, Min J, Richards HL, Carter D, Huang T, DeFea KA (2010) beta-Arrestins scaffold cofilin with chronophin to direct localized actin filament severing and membrane protrusions downstream of protease-activated receptor-2. J Biol Chem
285: 14318–14329. 10.1074/jbc.M109.055806</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M109.055806</ArticleId>
            <ArticleId IdType="pmc">PMC2863192</ArticleId>
            <ArticleId IdType="pubmed">20207744</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
